Cardinal Health, Inc. (CAH) — financial distillation

S&P 500 · United States · NYSE

CAHCIK 0000721371Period ends 2026-06-30Distilled SEC EDGAR XBRL company facts

Annual history (10-K)

Quarterly history (10-Q)

Two headline lines are shown to start. Click any item in a legend to add or remove it — every figure on the chart is one the table below also carries, for the period it names.

In brief, from the full filed history

  • Revenue grew from $95.99B (period ending 2009-06-30) to $254.25B (period ending 2026-06-30) — a 5.9% annual pace across 17 year(s) of filed history.
  • Net margin held close to 0.7% over that same span.
  • Across 53 tracked quarters, the strongest was $65.63B (quarter ending 2025-12-31) and the weakest was $21.43B (quarter ending 2014-03-31).

Annual — most recent 10-K

Line Value Period ends Form Filing
Revenue $254.25B 2026-06-30 10-K 0000721371-26-000038
Gross profit $9.77B 2026-06-30 10-K 0000721371-26-000038
Operating income $2.61B 2026-06-30 10-K 0000721371-26-000038
Net income $1.71B 2026-06-30 10-K 0000721371-26-000038
Diluted EPS $7.23 2026-06-30 10-K 0000721371-26-000038
Total assets $57.30B 2026-06-30 10-K 0000721371-26-000038
Cash & equivalents $4.86B 2026-06-30 10-K 0000721371-26-000038
Operating cash flow $5.17B 2026-06-30 10-K 0000721371-26-000038

Quarterly — most recent 10-Q

Line Value Period ends Form Filing
Revenue $65.63B 2025-12-31 10-Q 0000721371-26-000006
Gross profit $2.40B 2025-12-31 10-Q 0000721371-26-000006
Operating income $707.0M 2025-12-31 10-Q 0000721371-26-000006
Net income $467.0M 2025-12-31 10-Q 0000721371-26-000006
Diluted EPS $1.88 2025-09-30 10-Q 0000721371-25-000130
Total assets $58.08B 2025-12-31 10-Q 0000721371-26-000006
Cash & equivalents $2.78B 2025-12-31 10-Q 0000721371-26-000006
Operating cash flow $973.0M 2025-09-30 10-Q 0000721371-25-000130

Reading

The figures above are taken directly from filings with the U.S. Securities and Exchange Commission. The reading below was generated by a local language model from only those figures; it introduces no numbers of its own. It is not investment advice.

Cardinal Health, Inc. (CAH) operates with substantial scale, as evidenced by its fiscal year 2026 revenue of $254.25 billion and total assets of $57.30 billion. The company’s mix is predominantly focused on the healthcare distribution sector, serving a wide range of customers including acute care hospitals, clinics, surgery centers, and pharmacies.

The multi-year revenue trajectory reveals a steady growth pattern, expanding from $95.99 billion in 2009 to $254.25 billion in 2026 at an average annual rate of 5.9%. Despite this growth, net income margins have remained relatively stable around 0.7%, indicating consistent profitability despite fluctuations in earnings. Notably, the company experienced a significant net loss in 2020 and 2023 but rebounded with positive net income in subsequent years, demonstrating resilience.

In examining the next filing, investors should focus on Cardinal Health’s ability to sustain its growth trajectory amidst market challenges and regulatory pressures within the healthcare industry. Additionally, monitoring operating cash flow trends will be crucial, as the company generated $5.17 billion in operating cash flow for fiscal year 2026, indicating strong liquidity and financial flexibility to support ongoing operations and potential investments.


Source: SEC EDGAR company facts for CIK 0000721371 · filings index